MARSHALL WACE, LLP

Position in IPSC — Century Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in IPSC

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,318,084

-$204,215 QoQ

Shares Held

537,994

-20.1% QoQ

Ownership

0.297%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#30

of 98 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. IPSC ranks #165 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,318,084	537,994	-20.1%	Shares	Other	2026-08-13
2026-03-31	$1,522,299	673,584	+1143.7%	Shares	Other	2026-05-15
2025-09-30	$26,972	54,161	-61.2%	Shares	Other	2025-11-13
2025-06-30	$78,095	139,707	+293.4%	Shares	Other	2025-08-13
2024-12-31	$35,866	35,511	-67.8%	Shares	Other	2025-02-13
2023-03-31	$382,796	110,316	+91.9%	Shares	Other	2023-05-15
2022-12-31	$294,964	57,498	-91.8%	Shares	Other	2023-02-14
2022-09-30	$6,936,231	701,338	0.0%	Shares	Other	2022-11-14
2022-06-30	$5,891,238	701,338	0.0%	Shares	Other	2022-08-15
2022-03-31	$8,829,844	701,338	0.0%	Shares	Other	2022-05-16
2021-12-31	$11,123,220	701,338	+528.7%	Shares	Other	2022-02-14
2021-09-30	$2,806,648	111,552	+111.5%	Shares	Sole	2021-11-15
2021-06-30	$1,547,655	52,749	—	Shares	Sole	2021-08-25
No filing history on record for this holder in this stock.